A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study
Abstract
:1. Introduction
2. Methods
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Hajarizadeh, B.; Grebely, J.; Dore, G.J. Epidemiology and natural history of HCV infection. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 553–562. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Hepatitis C. 2021. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed on 10 September 2021).
- Iversen, J.; Grebely, J.; Catlett, B.; Cunningham, P.; Dore, G.J.; Maher, L. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia. Int. J. Drug Policy 2017, 47, 77–85. [Google Scholar] [CrossRef] [PubMed]
- Giles, E.L.; Robalino, S.; McColl, E.; Sniehotta, F.F.; Adams, J. The effectiveness of financial incentives for health behaviour change: Systematic review and meta-analysis. PLoS ONE 2014, 9, e90347. [Google Scholar] [CrossRef] [PubMed]
- Shen, C.; Dawe, J.; Traeger, M.W.; Sacks-Davis, R.; Pedrana, A.E.; Doyle, J.S.; Hellard, M.E.; Stoové, M. Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C: A systematic review. Int. J. Drug Policy. 2024, 133, 104562. [Google Scholar] [CrossRef] [PubMed]
- Cunningham, E.B.; Wheeler, A.; Hajarizadeh, B.; French, C.E.; Roche, R.; Marshall, A.D.; Fontaine, G.; Conway, A.; Bajis, S.; Valencia, B.M.; et al. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. Int. J. Drug Policy 2023, 111, 103917. [Google Scholar] [CrossRef] [PubMed]
- Wohl, D.A.; Allmon, A.G.; Evon, D.; Hurt, C.; Reifeis, S.A.; Thirumurthy, H.; Straub, B.; Edwards, A.; Mollan, K.R. Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies. Open Forum Infect. Dis. 2017, 4, ofx095. [Google Scholar] [CrossRef] [PubMed]
- Sulkowski, M.; Ward, K.; Falade-Nwulia, O.; Moon, J.; Sutcliffe, C.; Brinkley, S.; Haselhuhn, T.; Thomas, D.; Katz, S.; Herne, K.; et al. Randomized controlled trial of cash incentives or peer mentors to improve HCV linkage and treatment among HIV/HCV coinfected persons who inject drugs: The CHAMPS Study. J. Hepatol. 2017, 66, S719. [Google Scholar] [CrossRef]
- Marshall, A.D.; Conway, A.; Cunningham, E.B.; Valerio, H.; Silk, D.; Alavi, M.; Wade, A.; Lam, T.; Zohrab, K.; Dunlop, A.; et al. Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment. Drug Alcohol. Depend. 2022, 235, 109438. [Google Scholar] [CrossRef] [PubMed]
- Valerio, H.; Alavi, M.; Silk, D.; Treloar, C.; Martinello, M.; Milat, A.; Dunlop, A.; Holden, J.; Henderson, C.; Amin, J.; et al. Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study. Clin. Infect. Dis. 2021, 73, e69–e78. [Google Scholar] [CrossRef] [PubMed]
- Kistin, C.; Silverstein, M. Pilot Studies: A Critical but Potentially Misused Component of Interventional Research. JAMA 2015, 314, 1561–1562. [Google Scholar] [CrossRef] [PubMed]
- National Institutes of Health. National Centre for Complementary and Integrative Health. Pilot Studies: Common Uses and Misuses. Available online: https://www.nccih.nih.gov/grants/pilot-studies-common-uses-and-misuses (accessed on 28 March 2023).
Overall | Financial Incentive | Standard of Care | ||
---|---|---|---|---|
n = 57 | n = 28 | n = 29 | ||
Characteristic | N (%) | n (%) | n (%) | p-value * |
Age, median years (IQR) | 42 (37–49) | 41 (37–48) | 42 (37–51) | 0.652 |
Gender, Male | 36 (63%) | 20 (71%) | 16 (55%) | 0.328 |
Indigenous | 20 (35%) | 11 (39%) | 9 (31%) | 0.524 |
Unemployed | 51 (89%) | 26 (92%) | 25 (86%) | 0.548 |
Homeless | 8 (14%) | 5 (17%) | 3 (10%) | 0.457 |
Completed Year 10 | 45 (78%) | 21 (75%) | 24 (82%) | 0.747 |
Imprisoned in past 6 months | 8 (14%) | 4 (14%) | 4 (13%) | 0.612 |
Injected daily last month | 21 (36%) | 14 (50%) | 7 (24%) | 0.022 |
Main drug injected last month, methamphetamine | 25 (43%) | 16 (57%) | 9 (31%) | 0.068 |
Self-report hazardous alcohol use (AUDIT-C) | 6 (10%) | 2 (7%) | 4 (13%) | 0.612 |
Currently receiving OAT | 33 (57%) | 13 (46%) | 20 (68%) | 0.100 |
Currently receiving OAT, buprenorphine | 19 (33%) | 8 (28%) | 11 (37%) | 0.164 |
Self-report ever treated for HCV | 18 (31%) | 10 (35%) | 8 (27%) | 0.509 |
Liver disease stage, median kPa (IQR) | 5.6 (4.6–7.9) | 5.2 (4.2–7.4) | 6.7 (5.3–9.7) | 0.025 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marshall, A.D.; Conway, A.; Cunningham, E.B.; Valerio, H.; Silk, D.; Alavi, M.; Tillakeratne, S.; Wade, A.; Lam, T.; Zohrab, K.; et al. A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study. Viruses 2024, 16, 1763. https://doi.org/10.3390/v16111763
Marshall AD, Conway A, Cunningham EB, Valerio H, Silk D, Alavi M, Tillakeratne S, Wade A, Lam T, Zohrab K, et al. A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study. Viruses. 2024; 16(11):1763. https://doi.org/10.3390/v16111763
Chicago/Turabian StyleMarshall, Alison D., Anna Conway, Evan B. Cunningham, Heather Valerio, David Silk, Maryam Alavi, Shane Tillakeratne, Alexandra Wade, Thao Lam, Krista Zohrab, and et al. 2024. "A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study" Viruses 16, no. 11: 1763. https://doi.org/10.3390/v16111763
APA StyleMarshall, A. D., Conway, A., Cunningham, E. B., Valerio, H., Silk, D., Alavi, M., Tillakeratne, S., Wade, A., Lam, T., Zohrab, K., Dunlop, A., Connelly, C., Cock, V., Burns, C., Henderson, C., Christmass, M., Dore, G. J., & Grebely, J., on behalf of the ETHOS Engage Study Group. (2024). A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study. Viruses, 16(11), 1763. https://doi.org/10.3390/v16111763